Zu "941678-49-5" wurden 4 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Ruxolitinib
Ruxolitinib

Artikelnummer: Cay11609-1

Janus-associated kinases (JAKs) are cytoplasmic tyrosine kinases that are required for activating the signaling of certain cytokines and growth factor receptors. A JAK2 gene fusion mutation, JAK2V617F, that causes unchecked activation of various growth factors and cytokines, has been linked to myeloproliferative...
Schlagworte: INCB 018424, betaR-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
Anwendung: Jak1/2 inhibitor
CAS 941678-49-5
MW: 306.4 D
ab 34,00 €
Bewerten
Ruxolitinib
Ruxolitinib

Artikelnummer: AG-CR1-3624-M100

White to off-white solid. Soluble in DMSO or ethanol. Insoluble in water. Antineoplastic, anti-inflammatory and immunomodulating agent, Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50 = 322nM), Affects DC...
Schlagworte: INCB018424, INC 424
Anwendung: JAK1 inhibitor, JAK2 inhibitor
CAS 941678-49-5
MW: 306,4 D
ab 72,00 €
Bewerten
Ruxolitinib
Ruxolitinib

Artikelnummer: TGM-T1829-100mg

Description: Ruxolitinib (INCB018424) is a JAK1/2 inhibitor (IC50=3.3/2.8 nM) that is potent and selective. Rixolitinib exhibits antitumor activity and induces autophagy and apoptosis. Target: Mitophagy, Autophagy, Apoptosis, Tyrosine Kinases, JAK. Smiles: N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12....
Schlagworte: INCB018424, (R)-Ruxolitinib
Anwendung: Targets Janus kinase 1 [EC:2.7.10.2] (JAK1)
CAS 941678-49-5
MW: 306.36 D
ab 54,00 €
Bewerten
INCB018424
INCB018424

Artikelnummer: LKT-I5210.5

JAK1/2 inhibitor.
Schlagworte: Ruxolitinib
Anwendung: Janus kinase 1 (JAK1) inhibitor, janus kinase 2 (JAK2) inhibitor
CAS 941678-49-5
MW: 306.37 D
ab 136,00 €
Bewerten